| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JAUT.2009.02.008 |
| P698 | PubMed publication ID | 19324520 |
| P50 | author | Yehuda Shoenfeld | Q1515807 |
| Ricard Cervera i Segura | Q53547424 | ||
| José A Gómez-Puerta | Q55071271 | ||
| Guillermo J Pons-Estel | Q60162040 | ||
| Miguel Ingelmo | Q73600642 | ||
| Silvia Bucciarelli | Q114416206 | ||
| Miguel A Plasín | Q114416217 | ||
| Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies) | Q114416229 | ||
| P2093 | author name string | Gerard Espinos | |
| Joan Plaza | |||
| P433 | issue | 3-4 | |
| P921 | main subject | patient | Q181600 |
| catastrophic antiphospholipid syndrome | Q5051580 | ||
| P304 | page(s) | 240-245 | |
| P577 | publication date | 2009-03-26 | |
| P1433 | published in | Journal of Autoimmunity | Q15716783 |
| P1476 | title | Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry". | |
| P478 | volume | 32 |
| Q33418663 | 36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature. |
| Q53245134 | A 26-year-old white man with a systemic lupus erythematosus flare and acute multiorgan ischemia: Vasculitis or thrombosis? |
| Q51160259 | A case of catastrophic antiphospholipid syndrome, which presented an acute interstitial pneumonia-like image on chest CT scan. |
| Q51144375 | Abdominal pain, flank pain, blurry vision, and lower extremity weakness in a 16-year-old female. |
| Q36894167 | Accelerated arterial and venous clots in a young pregnant woman: a saga of thrombotic storm |
| Q59075500 | An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions |
| Q37853593 | An approach to the patient with retiform purpura |
| Q88984101 | An extraordinary case of recurrent stroke, disseminated thrombosis and endocarditis |
| Q92639094 | Anaesthetic considerations for patients with antiphospholipid syndrome undergoing non-cardiac surgery |
| Q37628253 | Anesthetic management of antiphospholipid syndrome patients who underwent cardiac surgery: three cases report |
| Q90312460 | Antiphospholipid Syndrome and Kidney Involvement: New Insights |
| Q33921875 | Antiphospholipid antibodies in critically ill patients |
| Q30235423 | Antiphospholipid syndrome |
| Q33413394 | Antiphospholipid syndrome in renal transplantation |
| Q88984114 | Antiphospholipid syndrome masquerading as a case of infective endocarditis |
| Q38596401 | Antiphospholipid syndrome presenting as cerebral venous sinus thrombosis: a case series and a review |
| Q38410376 | Antiphospholipid syndrome: an update |
| Q83286182 | Antiphospholipid syndrome: unusual clinical presentations |
| Q36566894 | Antiphospholipids Syndrome Complicated by a Systemic Capillary Leak-Like Syndrome Treated With Steroids and Intravenous Immunoglobulins: A Case Report |
| Q24185813 | Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndrome |
| Q45230040 | CAPS Registry |
| Q37076964 | CAPS: a rare acute abdomen. |
| Q33419886 | Catastrophic APS in the context of other thrombotic microangiopathies |
| Q53758664 | Catastrophic Antiphospholipid Syndrome. |
| Q92986354 | Catastrophic antiphospholipid antibody syndrome as a first manifestation of primary antiphospholipid antibody syndrome in a middle-aged man |
| Q41244904 | Catastrophic antiphospholipid antibody syndrome in a child with thrombotic microangiopathy |
| Q47555812 | Catastrophic antiphospholipid lung syndrome in young female with repeated abortions |
| Q37223858 | Catastrophic antiphospholipid syndrome (CAPS) induced by influenza A virus subtype H1N1. |
| Q45912780 | Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'. |
| Q37077038 | Catastrophic antiphospholipid syndrome in childhood: presentation with an inferior caval vein mass |
| Q38792177 | Catastrophic antiphospholipid syndrome in pregnancy, a diagnosis that should not be missed |
| Q41870499 | Catastrophic antiphospholipid syndrome presenting with sudden renal failure: The lesson lies in vascular lesions |
| Q50949676 | Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations. |
| Q33412407 | Catastrophic antiphospholipid syndrome with severe acute thrombotic microangiopathy and hemorrhagic complications |
| Q27009935 | Catastrophic antiphospholipid syndrome: a clinical review |
| Q26825077 | Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease |
| Q54037099 | Catastrophic antiphospholipid syndrome: task force report summary. |
| Q34526465 | Catastrophic cerebral antiphospholipid syndrome presenting as cerebral infarction with haemorrhagic transformation after sudden withdrawal of warfarin in a patient with primary antiphospholipid syndrome |
| Q33404707 | Clinical causes and treatment of the thrombotic storm |
| Q64092966 | Complement in the Pathophysiology of the Antiphospholipid Syndrome |
| Q37642830 | Current management of antiphospholipid syndrome-related thrombosis |
| Q37954539 | Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report |
| Q57656741 | Cutaneous necrosis of lower extremity as the first manifestation of catastrophic antiphospholipid syndrome |
| Q37826115 | Cutting edge issues in Goodpasture's disease |
| Q37453947 | Developments in the clinical understanding of lupus |
| Q30235356 | Diagnosis and management of catastrophic antiphospholipid syndrome |
| Q48855646 | Extended Antiphospholipid Antibodies Screening in Systemic Lupus Erythematosus Patients |
| Q33438290 | Fatal antiphospholipid syndrome following endoscopic transnasal-transsphenoidal surgery for a pituitary tumor: A case report |
| Q34821893 | Guidelines for the treatment of antiphospholipid syndrome |
| Q30276550 | Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue |
| Q37982121 | Guidelines on the investigation and management of antiphospholipid syndrome |
| Q34122035 | Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis |
| Q35729575 | Immune mediated diseases and immune modulation in the neurocritical care unit |
| Q37686732 | Immunoadsorption for systemic lupus erythematosus. |
| Q55128383 | Immunomodulation in the Treatment of Refractory Catastrophic Antiphospholipid Syndrome. |
| Q40115024 | Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies. |
| Q93185027 | Intracardiac thrombus in a patient with catastrophic antiphospholipid syndrome: an autopsy case report and review of the literature |
| Q37873722 | Intravenous immunoglobulin therapy in rheumatic diseases |
| Q37058776 | Latest advances in connective tissue disorders |
| Q60959332 | Malignant benign hematology |
| Q53096115 | Neurological presentations of the antiphospholipid syndrome: three illustrative cases. |
| Q37269605 | Occult pulmonary mucosa-associated lymphoid tissue lymphoma presenting as catastrophic antiphospholipid antibody syndrome. |
| Q38697342 | Organ Damage and Quality of Life in Antiphospholipid Syndrome. |
| Q47104714 | Pharmacologic Complement Inhibition in Clinical Transplantation. |
| Q33404240 | Platelets in pulmonary vascular physiology and pathology |
| Q38359475 | Postoperative risk of venous thromboembolism in rheumatic disease patients |
| Q53134970 | Probable catastrophic antiphospholipid syndrome complicated with primary sclerosing cholangitis. |
| Q86984388 | Renal involvement in antiphospholipid syndrome |
| Q87467570 | Renal involvement in antiphospholipid syndrome |
| Q27021256 | Rituximab and its therapeutic potential in catastrophic antiphospolipid syndrome |
| Q64959086 | Safety of retrievable inferior vena cava filters in patients with the antiphospholipid syndrome. |
| Q90181658 | Successful treatment of catastrophic antiphospholipid syndrome with therapeutic plasma exchange: a case report |
| Q30243901 | Systematic review of case reports of antiphospholipid syndrome following infection. |
| Q53159273 | Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. |
| Q42123111 | The flare up of catastrophic antiphospholipid syndrome: a report of an immunosuppressive withdrawal-induced case. |
| Q34966670 | The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome |
| Q36053839 | The role of plasmapheresis in critical illness |
| Q33434497 | Thrombocytopenic syndromes in pregnancy |
| Q38755260 | Treatment of catastrophic antiphospholipid syndrome |
| Q37809779 | Update on Antiphospholipid Syndrome in Children |
| Q37738701 | Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome |
| Q33408341 | Vascular endothelial cell function in catastrophic antiphospholipid syndrome: a case report and review of the literature |
| Q90416101 | [Antiphospholipid syndrome : Update on diagnostics and management] |
| Q87831212 | [Antiphospholipid syndrome] |
Search more.